Milestones
Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets
Indoco Remedies receives final ANDA approval from USFDA for Pregabalin capsules
USFDA successfully completes inspection at Indoco’s API Kilo Lab manufacturing facility and IAS division without any observations
Indoco receives the 'Digital Health Innovator Company of the Year' award
Warren Remedies Private Limited, a wholly owned subsidiary of Indoco Remedies commences commercial production of Pharmaceutical Intermediates and APIs.
Warren Remedies Private Limited, 100% subsidiary of Indoco Remedies Limited launched oral care products.
Indoco Remedies receives EIR from USFDA and confirms the closure of inspection at its state-of-the-art plant I in Goa
Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets
Indoco wins the SAP ACE Award 2023 in the 'GAME CHANGER' category
Indoco Analytical Solutions (IAS) receives the 'Best Customer Service Provider - Pharma and Healthcare' award
Indoco's Goa facility - Plant III receives EU GMP certification from the German Health Authority
Indoco wins the Vibrant Goa Inspiration Award
Indoco's Baddi facility (Unit I) receives GMP certification from EU Health Authority
Indoco wins the Excellence in Anti-Counterfeiting Packaging Award
Indoco's Baddi facility (Unit III) receives EUGMP certification from Health Authority of Germany
Indoco acquires 85 % equity stake in US based FPP Holding Company, LLC.
Indoco receives EIR for its manufacturing facility in Goa (Plant I)
Excellence in Pharma Supply Chain Management award for Indoco!
Indoco wins the "GOA BEST EMPLOYER BRAND AWARD 2023"
Indoco wins the Lead 50 (Next) Supply Chain Award
Sundeep Sir inaugurates the new OSD block at Waluj plant
ATM honoured with the Champion brand of the year with a Silver Impact Award by Pronto Consult Consumer Award
Indoco completed 75 years of excellence on 23rd August, 2022
Indoco bags the Digital Pharma Marketing Excellence Award for being the 'Digitally Visible Company of the Year' at DIGIPHARMAX 2022
EDQM grants CEP for Lacosamide API to Indoco
Indoco receives the 'IDMA Margi Patel Choksi Memorial Best Patent Awards 2019-2021'
Goa plant I completes 25 years of excellence in April 2022
Indoco Remedies receives USFDA approval for Lacosamide Injection USP
Indoco Remedies receives USFDA approval for Lacosamide Tablets
Indoco ranks 24th in the Indian Pharma Market (IPM) for the month of January'22. The Company's value growth of 44.9% is higher than the industry growth of 13.9%. There has been an impressive spur in volumes (unit) growth of 34.1%
CYCLOPAM wins the PCCA 'Platinum Brand Impact Award' for March 2021 presented by Pronto Consult Consumer Award
KARVOL PLUS wins the PCCA 'Best Innovative Campaign' Award for January 2021 presented by Pronto Consult Consumer Award
Indoco announces the launch of Brinzolamide Ophthalmic Suspension 1% in the US market by Teva Pharmaceuticals
Indoco wins major tenders in Germany for Allopurinol Tablets
Indoco's Kidodent receives the 'Most Trusted Pediatric Toothpaste for Regular Use' Award at the Pediatrics Conference 2020 organised by CIMS Medica India
Baddi plant I inaugurates new Liquid Block
Indoco receives USFDA approval for Apixaban Tablets 2.5 mg & 5 mg
Indoco awarded with the IDMA Formulations Best Patent Award 2018-19 for 2 formulation patents – Diclofenac & Quetiapine
Olopatadine ANDA filed from Indoco's Goa Plant II receives USFDA approval
AnaCipher Clinical Research receives BE study approval from WHO
First consignment of Glycopyrrolate Injection dispatched from Goa Plant II for launch in USA
Indoco receives USFDA approval for Succinylcholine Chloride Injection USP
Indoco receives USFDA approval for Olanzapine Tablets
Indoco's Clinical Research Organisation receives zero 483s from USFDA
Indoco's stalwart brand CYCLOPAM crosses Rs. 100 crs. sales (as per IMS)
Indoco successfully completes UK-MHRA inspection at Goa Plant II
UK-MHRA reinstates full GMP status for Indoco's Goa Plant I
USFDA clears Indoco's Goa Plant II & III
Indoco gets European Patent Grant for unique process of Brinzolamide Eye Drops
Indoco wins the IDMA Formulations Patent Award 2017-18 for 1 International and 2 Indian patent
Indoco's new solid dosages facility at Baddi receives UK-MHRA approval
Indoco's Sterile Manufacturing Facility (Plant II) Clears USFDA Inspection
Indoco commissions New API manufacturing facility at Patalganga
Indoco's Goa Plant II & III clears USFDA inspection
Indoco's API manufacturing facilities at Patalganga and Rabale successfully clear USFDA inspection
Indoco's API Patalganga site receives Renewed Accreditation Certificate from The Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Indoco receives the IDMA Best Indian Patent Award for five API Process Patents
Indoco's Goa plant III receives EU GMP certification
Indoco receives the Express Pharma Export Excellence Award 2017
Indoco receives UKMHRA approval for solid dosages Plant I in Goa
Indoco receives the IDMA Best Patent Award for four API Process Patents
Indoco receives patent grant for Linezolid & Brinzolamide (FDFs) from United States Patent and Trademark Office (USPTO)
Indoco Honoured with the IDMA Best Patent Award for Three International Patents
Indoco achieves a milestone of Rs.1000 Crs
Indoco acquires Oral Solid Dosage manufacturing facility in Baddi from Micro Labs Ltd., Bangalore
Indoco's Allopurinol ANDA gets USFDA approval
Indoco climbs 187 ranks up - Fortune India
Indoco receives USFDA approval for solid dosages Plant I in Goa
Indoco honoured with the 'Best Patent Award' by PHARMEXCIL in the Bulk Drugs / API category
Indoco wins IDMA Patent Appreciation Award for Betaxolol
Indoco acquires Piramal's Clinical Research division
Inauguration of New GLP Analytical facility for Formulation
US-FDA approves Sterile (Plant II) and Solid Dosages (Plant III) facilities in Goa
IDMA Best Patent Award for Tazarotene & Adapalene
Indoco announced the signing of an agreement with DSM, a € 9 billion Company, for commercial cooperation for Active Pharmaceutical Ingredients (APIs). Indoco and DSM have formed a strategic alliance, wherein DSM shall be marketing and selling the APIs manufactured by INDOCO
Innovation in Quality Award at CPhI Pharma Awards
Indoco received the Silver Quality Excellence Award for Sterile Manufacturing Facility in Goa and Solid Dosages Facility in Baddi (Himachal\Pradesh) at IDMA's Golden Jubilee celebrations
Indoco Remedies teams up with ASPEN, South Africa by licensing out intellectual property (dossiers) for marketing its products in emerging markets covering 30 countries, including SA, Brazil, Mexico, Venezuela, Russia & Australia
Indoco Remedies licenses out technology to Watson Pharmaceuticals Inc. USA. Under the terms of profit sharing agreement, Indoco will develop, manufacture and supply a basket of sterile products to Watson for the US market
UK-MHRA approval for the Solid Oral Dosage forms at Baddi Plant
Export sales exceeded Rs. 1 Billion in the FY 08-09
Successfully faced Slovenia audit for the Sterile Facility at Goa Plant II for the Injections Area
IDMA Quality Excellence Awards 2008 - The Sterile Facility at Goa Plant II received the Gold Award and the Solid Dosage Forms and Externals Facility at Goa Plant I received the Silver Award
TGA (Australia) approval for the Solid Dosage, Liquid Orals and Creams &Ointments Dosage forms at GOA Plant I
First shipment of Diclofenac Ophthalmic solution shipped to USA against an approved ANDA
Successfully faced Slovenia audit for the Solid Oral Dosage forms at Baddi Plant
MCC (South Africa) approval for the Solid Dosage facility at GOA Plant I and for the Sterile facility at Goa Plant II
ANVISA (Brazil) approval for the Solid Dosage facility at GOA Plant I
Commencement of exports to the US markets
Launch of Warren-Excel and Spera - two specialty marketing divisions
US-FDA approval for Ophthalmic facility, Plant-II in GOA
Contract signed for supply of 18 generic products to German Market
2 ANDAs filed with USFDA
Commencement of liquid manufacturing facility at Baddi, Himachal Pradesh
New R&D Centre at Rabale, near Mumbai becomes functional
Solid Dosage facility at Goa Plant I re-inspected & approved by UK-MHRA
UK-MHRA approval for Creams & Ointments facility
Darmstadt-Germany approves our Goa facility for Solid Dosage manufacturing
Acquisition of LaNOVA Chem Pvt. Ltd. with its brand new API manufacturing facility of international standards
Launch of Surge - a specialty marketing division
First ANDA filed on the basis of Exhibit batches manufactured in our sterile facility in Goa
Development Contracts for injectable products signed with a US Company
Tablet capacity doubled by commissioning an extended facility in the existing UK-MHRA approved plant
Shares of the Company listed on BSE and NSE
First Contract for Development services with US Company
Karvol brand acquisition from Solvay Pharmaceuticals Pvt. Ltd
Four Patent applications filed
Company jumps five ranks in two yrs in the ORG-IMS Retail Audit
UK-MHRA approval for the Solid Dosage facility at Plant I
Exports to regulated markets commence
First contract for Dossier Development with European company
Domestic Marketing makes a foray into the lifestyle segment
State-of-the-art sterile facility, Plant II commissioned at Verna Goa
New Corporate Office at Indoco House
Acquisition of Warren. Indoco makes presence in Ophthalmic & Dental Segments
Turnover crosses Rs. 100 cr.
Commencement of production in Goa Plant I
R&D recognized by DSIR
New manufacturing plant at Waluj, Aurangabad
Turnover crosses Rs. 10 Cr.
Inauguration of new office at Andheri
Turnover crosses Rs. 1 Cr.
New manufacturing unit at Andheri
Suresh G. Kare takes over as Managing Director
23rd August 1947, Indoco Remedies Limited was formed